Pds Biotechnology

Developer of immunostimulatory nanoparticle vaccine for cancer and infectious diseases

placeNorth Brunswick, New Jersey, United States calendar_todayFounded 2005 groups26 employees language pdsbiotech.com

Registered entities

Social engagement

Social engagement: 5.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record.

Investor typeCountShare
Venture capital333%
Bank & private debt111%
Other / undisclosed556%

Recent activity

13 May 2026
Event
PDS Biotech conference call and webcast
6 May 2026
Event
conference call and webcast to report financial results for the quarter ended March 31, 2026
Coming soon